ERCC1 and non-small cell lung carcinoma: Findings in the meta-analysis of Roth et al. supported the hypothesis that ERCC1 is associated with response to chemotherapy based on platinum and OS in advanced NSCLC, but the study of Booton et al. did not confirmed that hypothesis [7, 14].